Aptinyx Cash and Cash Equivalents 2011-2026 | APTX

Annual Cash and Cash Equivalents Aptinyx

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
56.2 M	106 M	141 M	98.8 M	151 M	92.6 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
151 M	56.2 M	108 M

Quarterly Cash and Cash Equivalents Aptinyx

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
44.6 M	56.2 M	66.6 M	-	100 M	106 M	125 M	129 M	147 M	141 M	141 M	141 M	141 M	98.8 M	98.8 M	98.8 M	98.8 M	151 M	151 M	151 M	151 M	92.1 M	92.1 M	92.1 M	-	17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
151 M	17 M	110 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	12.9 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	6.15 M	-	-45.71 %	$ 1.2 M	Canada
Athira Pharma ATHA	48.4 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	4.88 M	-	17.91 %	$ 11.1 M	USA
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	37.4 M	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	17.1 M	-	-16.42 %	$ 249 M	USA
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
AVEO Pharmaceuticals AVEO	70.5 M	-	-	$ 521 M	USA
Atreca BCEL	30.8 M	-	-11.76 %	$ 5.79 M	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Agenus AGEN	76.1 M	$ 3.27	-1.8 %	$ 1.17 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	89.1 M	$ 28.72	-5.0 %	$ 1.66 B	USA
bluebird bio BLUE	222 M	-	-	$ 546 M	USA
Brickell Biotech BBI	10.9 M	-	-5.38 %	$ 6.06 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Baudax Bio BXRX	5.26 M	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	59.5 M	-	-10.95 %	$ 876 K	USA